United States Anti-Inflammatory Therapeutics Market Report

United States Anti-Inflammatory Therapeutics Market Report, by Drug Class (Anti-Inflammatory Biologics, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Immune-Selective Anti-inflammatory Derivatives), Indication (Arthritis, Chronic Obstructive Pulmonary Diseases, Multiple Sclerosis, Inflammatory Bowel Disease, Asthma, Tendonitis), End User (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies)- United States Market Share, Trend, Analysis & Forecast , 2019 - 2028

Report Code : 10799 | Publish Date : Upcoming | Industry : Healthcare | Geography : Country


Inflammation is a natural immune response which primarily activates to clear dead cells and eliminate the cause of injury. But in some cases, body inappropriately triggers the inflammation to fight back with own cells which may lead to autoimmune disease like asthma, COPD etc. Rise in the consumption of anti-inflammatory drugs owing to appearance of target based anti-inflammatory biologics which are more potent and having minimum side effects as compared to conventional drugs. The anti-inflammatory therapeutics is a drug which facilitates acute and chronic pain as well as inflammation (redness, swelling and pain). 

Market Dynamics- United States Anti-Inflammatory Therapeutics Market

The United States anti-inflammatory therapeutics market is observing lucrative during forecast period of 2021 to 2027. The anti-inflammatory drugs are used in the treatment of asthma and arthritis. The major factors such as rising incidences of autoimmune and respiratory conditions is propelling growth of United States anti-inflammatory therapeutics market. New drug pipelines is also refuelling growth of United States anti-inflammatory therapeutics market. Increasing adoptions rate of anti-inflammatory drugs is driving the growth of United States anti-inflammatory therapeutics market. However, side effects of anti-inflammatory drugs and patent expiry is hindering the growth of United States anti-inflammatory therapeutics market. 

COVID-19 Impact on United States Anti-Inflammatory Therapeutics Market 

 The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the anti-inflammatory therapeutics market. In addition, complete analysis of changes on anti-inflammatory therapeutics organizations expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. Owing to inflammation caused by COVID-19 virus which causes severe pneumonia the anti-inflammatory therapeutics market is witnessing rapid growth.  The cytokine rage is chief cause of death in COVID-19 affected patients. Some of the consequences of severe inflammation and cytokine storm comprised of the acute respiratory distress syndrome, acute lung injury and multiple organ dysfunction syndrome which leads to research and development of anti-inflammatory drugs for treatment of the inflammation caused by the COVID-19. Thus, such factors have impacted positively on the growth of anti-inflammatory therapeutics market during the COVID-19 pandemics. 


United States Anti-Inflammatory Therapeutics Market- Segmental Overview 

The United States anti-inflammatory therapeutics market is segmented into drug class, indications and end user. 

United States Anti-Inflammatory Therapeutics Market by Drug Class 

Based on drug class, the United States anti-inflammatory therapeutics market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs, corticosteroids, immune-selective anti-inflammatory derivative and other. In which anti-inflammatory biologics is estimated to dominate the market in 2020. The rising elderly population is propelling growth of United States anti-inflammatory therapeutics market. The rising prevalence of chronic diseases is also boosting growth of United States anti-inflammatory therapeutics market. 

United States Anti-Inflammatory Therapeutics Market by Indications 

Based on indications, the United States anti-inflammatory therapeutics market is bifurcated into arthritis, chronic obstructive pulmonary diseases, multiple sclerosis, inflammatory bowel diseases, asthma, tendonitis and other. In which multiple sclerosis and tendonitis is also contributing in the growth of the United States anti-inflammatory therapeutics market. The rising use of OTC anti-inflammatory medicines is propelling growth of United States anti-inflammatory therapeutics market. The rising incidences of multiple sclerosis is also boosting growth of United States anti-inflammatory therapeutics market. 

United States Anti-Inflammatory Therapeutics Market by End User 

Based on end user, the United States anti-inflammatory therapeutics market is categorised into the hospital pharmacies, online pharmacies and retail pharmacies. In which online pharmacies is also contributing in the growth of United States anti-inflammatory therapeutics market. The high surge in use of internet is propelling growth of United States anti-inflammatory therapeutics market. The rising adoption of technology is also boosting growth of United States anti-inflammatory therapeutics market. The growing offerings by online pharmacies is also driving the growth of United States anti-inflammatory therapeutics market. 

Key Players in Anti-Inflammatory Therapeutics Market 

The major key players operating in the market are Amgen Inc, Astrazeneca Plc., Eli Lily And Company., Hoffmann-La Roche Ag, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Ag and Pfizer Inc among others. 

Key Developments in Anti-Inflammatory Therapeutics Market 

Jun 2020: FDA approved Novartis Ilaris which contains canakinumab for new indication to treat adult-onset still’s disease (AOSD). 

March 2020: GSK’s consumer healthcare launched the biggest innovation in the U.S. as Over the counter oral pain relief category under the brand name of Advil dual action which comprised of the acetaminophen and ibuprofen.

The study comprised of the anti-inflammatory therapeutics market. In which study analysed the various segment of the market such as drug class, indication and end user. The study also comprised of dominating segment of the market. The drug class segments is dominated by anti-inflammatory biologics. Likewise, indication segment is dominated by arthritis and end user segment is dominated by hospital pharmacies. The study also covers the impact of COVID-19 on the anti-inflammatory therapeutics market and concludes that the COVID-19 has almost affected every market is healthcare industries positively or negatively. Owing to inflammation caused by COVID-19 virus which causes severe pneumonia the anti-inflammatory therapeutics market is witnessing rapid growth.  The cytokine rage is chief cause of death in COVID-19 affected patients. Some of the consequences of severe inflammation and cytokine storm comprised of the acute respiratory distress syndrome, acute lung injury and multiple organ dysfunction syndrome which leads to research and development of anti-inflammatory drugs for treatment of the inflammation caused by the COVID-19. Thus, such factors have impacted positively on the growth of anti-inflammatory therapeutics market during the COVID-19 pandemics. The study also imparts the major key players operating in the market. 

Why to buy this report 

  • The report offers changing market dynamics in the anti-inflammatory therapeutics markets industry, presenting historical, current and projected market size in terms of value (USD Million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of the anti-inflammatory therapeutics market.
  • It presents a comprehensive assessment of countries exhibiting promising growth, potential and niche segments and a neutral perspective of the anti-inflammatory therapeutics market.
  • The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of anti-inflammatory therapeutics market.